Evidence map›Paper›PMID 36627518›Full record

ArticleJournal of digital imaging2023

Automated Bone Tumor Segmentation and Classification as Benign or Malignant Using Computed Tomographic Imaging.

Ilkay Yildiz Potter, Diana Yeritsyan, Sarah Mahar, Jim Wu, Ara Nazarian, Aidin Vaziri, Ashkan Vaziri

Open access · greenAbstract read
In one paragraph

Article in Journal of digital imaging, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Ilkay Yildiz PotterBioSensics LLC, 57 Chapel Street, Newton, MA, 02458, USA. ilkay.yildiz@biosensics.com.ORCID 0000-0002-2827-7672
Diana YeritsyanBeth Israel Deaconess Medical Center (BIDMC), Harvard Medical School, 330 Brookline Avenue, Boston, MA, 02215, USA.
Sarah MaharBeth Israel Deaconess Medical Center (BIDMC), Harvard Medical School, 330 Brookline Avenue, Boston, MA, 02215, USA.
Jim WuBeth Israel Deaconess Medical Center (BIDMC), Harvard Medical School, 330 Brookline Avenue, Boston, MA, 02215, USA.
Ara NazarianBeth Israel Deaconess Medical Center (BIDMC), Harvard Medical School, 330 Brookline Avenue, Boston, MA, 02215, USA.
Aidin VaziriBioSensics LLC, 57 Chapel Street, Newton, MA, 02458, USA.
Ashkan VaziriBioSensics LLC, 57 Chapel Street, Newton, MA, 02458, USA.
Beth Israel Deaconess Medical Center · USBioSensics (United States) · US

Funding

Software Solution for Clinical Management of Musculoskeletal TumorsR43CA254835 · NCI · BIOSENSICS, LLC · PI NAZARIAN, ARA, VAZIRI, ASHKAN · 2020 to 2020
$256k
NCI NIH HHS R43 CA254835
6 · The paper itself

Abstract

The purpose of this study was to pair computed tomography (CT) imaging and machine learning for automated bone tumor segmentation and classification to aid clinicians in determining the need for biopsy. In this retrospective study (March 2005-October 2020), a dataset of 84 femur CT scans (50 females and 34 males, 20 years and older) with definitive histologic confirmation of bone lesion (71% malignant) were leveraged to perform automated tumor segmentation and classification. Our method involves a deep learning architecture that receives a DICOM slice and predicts (i) a segmentation mask over the estimated tumor region, and (ii) a corresponding class as benign or malignant. Class prediction for each case is then determined via majority voting. Statistical analysis was conducted via fivefold cross validation, with results reported as averages along with 95% confidence intervals. Despite the imbalance between benign and malignant cases in our dataset, our approach attains similar classification performances in specificity (75%) and sensitivity (79%). Average segmentation performance attains 56% Dice score and reaches up to 80% for an image slice in each scan. The proposed approach establishes the first steps in developing an automated deep learning method on bone tumor segmentation and classification from CT imaging. Our approach attains comparable quantitative performance to existing deep learning models using other imaging modalities, including X-ray. Moreover, visual analysis of bone tumor segmentation indicates that our model is capable of learning typical tumor characteristics and provides a promising direction in aiding the clinical decision process for biopsy.

Indexed as

Bone NeoplasmsTomography, X-Ray ComputedBiopsyFemaleHumansImage Processing, Computer-AssistedMachine LearningMaleRetrospective StudiesBone tumorClassificationComputed tomographyDeep learningSegmentation

Identifiers

PMID36627518
PMCPMC10287871
OpenAlexW4315489260

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.